REQUEST A DEMO
Total
USD $0.00
Search more companies

U2Bio Co. Ltd. (South Korea)

Main Activities: Biological Product (except Diagnostic) Manufacturing
Full name: U2Bio Co. Ltd. Profile Updated: January 06, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

The Company is a Korea-based company mainly engaged in the provision of diagnostic testing services. The Company is involved in the provision of the general diagnostic testing services, molecular diagnostic testing services, as well as medical information technology (IT) services. The general diagnostic testing services include the provision of diagnosis and inspection information such as immunological serology, hematology, urine and microbiology, and pathology excluding molecular diagnostics among in vitro diagnostic tests. The Molecular diagnostic testing services include the provision of diagnostic and testing information through tests such as urethritis, mastoiditis, vaginitis, and cervicitis. The medical IT services include the provision of customized medical services through software products. The Company was founded on January 02, 2009. and its shares are listed on KOREA NEW EXCHANGE(KONEX) on Jun 29, 2015.

Headquarters
65, Geoma-Ro, Songpa-Gu
Seoul; Seoul;

Contact Details: Purchase the U2Bio Co. Ltd. report to view the information.

Website: http://www.u2bio.co.kr

Basic Information
Total Employees:
Purchase the U2Bio Co. Ltd. report to view the information.
Outstanding Shares:
Purchase the U2Bio Co. Ltd. report to view the information.
Financial Auditors:
Purchase the U2Bio Co. Ltd. report to view the information.
Incorporation Date:
2009
Key Executives
Company Performance
Financial values in the chart are available after U2Bio Co. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
36.52%
Total operating revenue
36.29%
Operating profit (EBIT)
71.9%
EBITDA
71.3%
Net Profit (Loss) for the Period
42.48%
Total assets
23.45%
Total equity
57.24%
Operating Profit Margin (ROS)
4.66%
Net Profit Margin
0.8%
Return on Equity (ROE)
-4.03%
Debt to Equity Ratio
-7.69%
Quick Ratio
1.07%
Cash Ratio
-0.83%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?